Protagonist Therapeutics Inc. (PGF)
Market Open
29 Aug, 20:00
XBER 
NASDAQ (NMS) Primary XBER €
50. 50
+0.7
+1.41%
€
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0.75 Eps
€ 49.8
Previous Close Day Range
49.4 50.5
Year Range
32.2 57
Want to track PGF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 63 days
| PGF Protagonist Therapeutics Inc. 6 Nov 2025 (In 2 months) | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 5 Nov 2025 (In 2 months) | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 11 Aug 2025 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 6 Aug 2025 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 4 Aug 2025 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 6 May 2025 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 5 May 2025 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 25 Feb 2025 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 4 Nov 2024 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 31 Oct 2024 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 5 Aug 2024 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 1 Aug 2024 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 20 Jun 2024 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 2 May 2024 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 27 Feb 2024 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 6 Nov 2023 | | - Cons. EPS | - EPS |
| PGF Protagonist Therapeutics Inc. 2 Nov 2023 | | - Cons. EPS | - EPS |
PGF Earnings Reports FAQ
What is the earnings per share (EPS) for PGF?
The current EPS is 0.75.
When is the next earnings release date?
The next earnings release is expected to be on 2025-11-05, based on the PGF's typical earnings announcement schedule.
2025 © Marketlog. All Rights Reserved.
